Bryan Laraway
Impact in
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA Research and Splicing
- RNA modifications and cancer
-
- Cancer-related Molecular Pathways
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 2
- Advanced biosensing and bioanalysis techniques 1
- Metabolism, Diabetes, and Cancer 1
- Genetics, Bioinformatics, and Biomedical Research 1
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Rosalie C. Sears (2 shared papers)Megan L. Troxell (2 shared papers)Xiaoyan Wang (1 shared paper)Sara Tokarz (1 shared paper)Melissa Cunningham (1 shared paper)Xiaoli Zhang (1 shared paper)Amy Farrell (1 shared paper)Hugh Arnold (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Journal of Pediatrics (1 paper)Orphanet Journal of Rare Diseases (1 paper)EBioMedicine (1 paper)Translational Psychiatry (1 paper)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Bryan Laraway
10 papers receiving 325 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 193
- Oncology 75
- Neurology 35
- Cancer Research 33
- Genetics 22
Countries citing papers authored by Bryan Laraway
This map shows the geographic impact of Bryan Laraway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Laraway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Laraway more than expected).
Fields of papers citing papers by Bryan Laraway
This network shows the impact of papers produced by Bryan Laraway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Laraway. The network helps show where Bryan Laraway may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Laraway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 130 | |
| 2 | 2011 | 65 | |
| 3 | 2021 | 53 | |
| 4 | 2022 | 24 | |
| 5 | 2024 | 18 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 12 | |
| 8 | 2010 | 5 | |
| 9 | 2015 | 4 | |
| 10 | 2024 | 1 | |
| 11 | 2015 | 0 |
About Bryan Laraway
Bryan Laraway is a scholar working on Molecular Biology, Infectious Diseases, Neurology, Genetics and Biomedical Engineering, having authored 11 papers that have together received 330 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Graphene and Nanomaterials Applications (1 paper), Intestinal Malrotation and Obstruction Disorders (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Genetics, Bioinformatics, and Biomedical Research (1 paper). The work is most often cited by research in Molecular Biology (193 citations), Oncology (75 citations), Neurology (35 citations), Cancer Research (33 citations) and Genetics (22 citations). Bryan Laraway has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Rosalie C. Sears, Megan L. Troxell, Xiaoyan Wang, Sara Tokarz, Melissa Cunningham, Xiaoli Zhang, Amy Farrell, Hugh Arnold, Xiaoli Zhang and Colin J. Daniel. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Pediatrics, Orphanet Journal of Rare Diseases, EBioMedicine and Translational Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.